Event brings industry, academia, and government together to promote Maryland regional biotech activity
Utilizing NIST-developed materials that allow the formation of model tethered bilayer lipid membranes (tBLMs) at surfaces, researchers at the Institute of Biochemistry and the Department of Immunology and Cell Biology in Vilnius, Lithuania have functionally reconstituted an integral membrane protein toxin vaginolysin (VLY) and demonstrated the applicability of these tBLMs as a bioanalytical platform for the detection of bacterial vaginosis (BV).
COLLEGE PARK, Md. – The University of Maryland today announced the appointment of Thomas R. Fuerst, Ph.D., as the new director of the Institute for Bioscience and Biotechnology Research (IBBR). IBBR is a joint research enterprise created to enhance collaboration among the University of Maryland, College Park (UMD), the University of Maryland, Baltimore (UMB), and the National Institute of Standards and Technology (NIST) in the fields of medicine, biosciences, technology, quantitative sciences and engineering.
Eight Montgomery County high school students recently completed summer internships at IBBR as part of the annual internship program. In collaboration with the Montgomery County Public School System (MCPS), IBBR offers a limited number of high school internships for highly motivated MCPS students as part of the MCPS DNA Resource Center (DRC) program. The internship program provides highly motivated students the opportunity to work with mentors and explore careers in the fields of science and information technology.
In the current issue of the journal, Environmental Health Perspectives (121(2): A48-A53 (2013)), contributing author Carol Potera reviews the emerging uses of bacteriophage as antibiotic alternatives. The article “Phage Renaissance: New Hope Against Antibiotic Resistance”, examines several applications for phage-directed approaches, including food safety, medical, and water treatment. In the article, IBBR/Vet-Med faculty, Dr. Daniel Nelson, a world-renowned researcher on phage lysins, describes the inherent properties of phage enzymes as a viable approach in several applications.
Dr. Zvi Kelman (IBBR/NIST) has recently returned from Japan where he spent five weeks as an invited Fellow of the Japan Society for the Promotion of Science (JSPS). This program is designed to enable Japanese researchers to invite their foreign colleagues to Japan to participate in cooperative work and other academic activities. Dr. Kelman’s fellowship was also supported by NIST.
Dr. Zvi Kelman (IBBR/NIST), along with Dr. Sonja-Verena Albers (Max Planck Institute for Terrestrial Microbiology), recently co-chaired the 2013 Gordon Research Conference (GRC) “Archaea: Ecology, Metabolism & Molecular Biology”.
Drs. John Orban (Professor at the University of Maryland Institute of Bioscience and Biotechnology Research (IBBR) and Department of Chemistry and Biochemistry) and Philip Bryan (Professor at IBBR and Department of Bioengineering) have recently been awarded RO1 funding from the National Institutes of Health to study how an amino acid sequences, the building blocks of proteins, fold into a 3D conformation.
Please join us in congratulating Dr. David Vanderah (Institute for Bioscience & Biotechnology Research (IBBR) and National Institute of Standards and Technology (NIST)), recipient of the 2013 NIST Colleagues’ Choice Award. This annual award is given in recognition of non-supervisory NIST employees who, in the eyes of their colleagues, have made significant contributions that broadly advance the NIST mission and strategic goals or broadly contribute to the overall health and effectiveness of NIST. Dr.